RecruitingNot ApplicableNCT06640205

Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars

Clinical and Radiographic Assessment of I-PRF Versus Nano Mineral Trioxide Aggregate Combined with I-PRF Scaffold in Vital Pulp Therapy in Mandibular First Molars with Closed Apices: "Randomized Controlled Trial"


Sponsor

Future University in Egypt

Enrollment

51 participants

Start Date

Sep 3, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Assessment of I-PRF versus Nano Mineral trioxide aggregate Combined with I-PRF in pulpotomy in mature Mandibular First Molars


Eligibility

Min Age: 15 YearsMax Age: 30 Years

Inclusion Criteria9

  • Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.
  • Patients of either gender aged from 15-30.
  • Tooth should give positive response to cold test.
  • The tooth is restorable
  • Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
  • Patients who will agree to the consent and will commit to follow-up period.
  • Patients with mature root.
  • Patients with no internal or external resorption and no periapical lesions.
  • Soft tissues around the tooth are normal with no swelling or sinus tract.

Exclusion Criteria6

  • Patients with immature roots.
  • Haemostasias after 10 minutes can not be controlled after total pulpotomy
  • Patients with periapical lesions or infections.
  • Pregnant females.
  • Patients with fistula or swelling
  • Patients with necrotic pulp.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREpulpotomy

Removal of coronal pulp tissue and then placing pulpotomy agent


Locations(1)

Future university in egypt

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06640205


Related Trials